Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 41 results for "glenmark pharmaceuticals"

Glenmark Pharmaceuticals gets final approval for Tacrolimus Oi...

First Published: Wed, April 18 2018. 09:39 IST RECOMMENDED FOR YOU RECOMMENDED FOR YOU Business Standard, 1 day ago

15 images for glenmark pharmaceuticals

Business Standard, 2 weeks ago
Business Standard, 2 weeks ago
Sify, 2 months ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Money Today, 4 months ago
Money Control, 5 months ago
Sify, 5 months ago
Business Standard, 5 months ago
Business Standard, 4 months ago
Business Standard

Glenmark Pharma to begin phase 2b clinical trial of atopic dermatitis drug

Shares of Glenmark Pharma were trading 0.21 per cent higher at Rs 576 on BSE.
 Money Control2 days ago New products, over-the-counter business to fuel Glenmark's India growth  Business Standard3 days ago Glenmark Pharma shares plunge nearly 10 per cent after Rs 104 crore loss in Q3  Money Today2 months ago Glenmark Pharma shares dive nearly 10% after Q3 earnings  Business Standard2 months ago
Money Control

Market Update: IT, Pharma index outperforms led by TCS, Glenmark; Adani Ports up 3%; SBI most active

The market breadth was in favour of the advances with 936 stocks advancing while 746 declined and 362 remained unchanged. On the other hand, in the BSE, 1348 stocks advanced and 1142 declined and 150 remained unchanged.
 Money Control5 days ago
Business Standard

Glenmark recalls 100,000 bottles of drug over incorrect instrictions

The ongoing nationwide voluntary recall is a class III recall Last Updated at April 5, 2018 18:01 IST Glenmark Pharmaceuticals is recalling over 100,000 bottles of anti-inflammatory Indomethacin capsules from the US market due to incorrect instructions on the ...
 Business Standard2 weeks ago Glenmark recalls over 1 lakh bottles of anti-inflammatory drug in US  Money Control2 weeks ago

Easing of US-China Trade War Fears; Inflation Outlook Cut & Top Stocks to Sway the Market Today

Posted by Equitymaster The Indian stock markets closed sharply higher on Thursday after the Reserve Bank of India kept the repo rate unchanged at 6% in the first Monetary Policy Committee (MPC) meet of FY19, with the Sensex rising 578 points to 33,597, and ...
 Equitymaster.com1 week ago Indian Indices Recover Steadily, Key Sectors Rebound, and Top Stocks in Action  Equitymaster.com3 weeks ago Rising Dollar after Fed Minutes; F&O; Expiry and Top Stocks in Action Today  Equitymaster.com1 month ago Indian Indices Trade Marginally Lower; Energy Stocks Witness Losses  Equitymaster.com1 month ago
Business Standard

Glenmark, Helsinn Group tie up for CINV drug sale in India, Nepal

Glenmark Pharmaceuticals today said it has signed a licensing agreement with Swiss pharma player Helsinn Group to introduce 'Akynzeo' in India and Nepal, a drug that helps prevent chemo-related nausea and vomiting.The licensing agreement for Akynzeo ...
 Business Standard2 weeks ago Glenmark to market Helsinn's chemo-induced nausea drug in  Business Standard2 weeks ago Glenmark Pharmaceuticals and Helsinn Group enter into an exclusive licensing agreement  Business Standard2 weeks ago
Money Control

Glenmark Pharmaceuticals Ltd rose for a fifth straight session today

k is quoting at Rs 548.85, up 0.79% on the day as on 12:49 IST on the NSE. Glenmark Pharmaceuticals Ltd is down 39.39% in last one year as compared to a 17.87% gain in NIFTY and a 15.06% gain in the Nifty Pharma. Glenmark Pharmaceuticals Ltd rose for a fifth ...
 Business Standard1 month ago Glenmark Pharma rises 1%; enters into agreement with SCD Pharma  Money Control1 month ago Glenmark ties up with S. Korea's SCD for ophthalmic products  Business Standard1 month ago Glenmark ties up with South Korea#39;s SCD for ophthalmic products  Money Control1 month ago
Business Standard

Pricing woes force Cipla, Glenmark, Lupin to go slow on US drug pipeline

Companies to focus on complex products as tough competition in generics, customer consolidation impact profits Aneesh Phadnis | Mumbai Last Updated at February 27, 2018 13:05 IST Faced with pricing pressure, large Indian pharmaceutical companies are focusing ...
 Business Standard1 month ago
Sify

Despite poor Q3, HDFC Securities maintains BUY rating for Glenmark; here's why

HDFC Securities in a note has maintained a Target Price of Rs 780 on Glenmark and maintained a why. This is what they had to say: Glenmark's Q3 (FY 2017-18) performance was sub-par, as pricing pressure in the US business, higher R&D and forex losses weighed ...
 Sify2 months ago
Business Standard

Lupin, Dr Reddy's, Glenmark and Taro see up to 40% decline in the US sales

Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the ...
 Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less